Company / R&D per Share
CHAMPIONS ONCOLOGY, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.70
FY2025
5-year range
$0.46 / $0.70
FY2021-FY2025
Trend
+39.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.39 in FY2018 to $0.70 in FY2025.
Based on SEC 10-K filings.
0.70 in FY2025 with a 5-year CAGR of +2.5%.
Remained stable around $0.70 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 39.3% year-over-year.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.70 | +39.3% |
| FY2024 | $0.50 | -27.3% |
| FY2023 | $0.69 | +29.2% |
| FY2022 | $0.54 | +16.6% |
| FY2021 | $0.46 | -25.7% |
| FY2020 | $0.62 | +16.4% |
| FY2019 | $0.53 | +36.1% |
| FY2018 | $0.39 | -18.9% |
| FY2017 | $0.48 | -13.6% |
| FY2016 | $0.56 | +1545.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026